QuestionAI GovernanceImplementationHealthcare

What governance controls and response SLAs should clinical AI teams publish for high-risk output exceptions?

7 April 2026
Answered by Rohit Parmar-Mistry

Short answer

For clinical AI exceptions, document who can pause the system, who assesses patient impact and how an incident reaches a clinical safety lead. Response targets must match the care setting, coverage hours and applicable reporting duties.

Detailed answer

Clinical AI teams need published rules before exceptions happen

For clinical AI exceptions, document who can pause the system, who assesses patient impact and how an incident reaches a clinical safety lead. Response targets must match the care setting, coverage hours and applicable reporting duties.

Agree the exception plan with the clinical safety lead and the relevant legal and operational owners before sharing it with stakeholders. Test how the roles, response targets and handoffs work in the care setting.

The controls and SLAs that matter most in practice

Use severity definitions, escalation routes, response targets, human decision authority, evidence requirements and closure criteria as a checklist for the proposed process. Define the high-risk types, roles to contact, acknowledgement and containment targets, clinician review triggers, permitted evidence and closure conditions for that deployment.

  • Severity model: define what counts as a high-risk exception, for example patient-facing misinformation, unsafe recommendations, missing contraindication flags, or model outputs that conflict with approved clinical protocols.
  • Escalation chain: publish the first-line owner, senior clinical reviewer, technical incident owner, and governance lead.
  • Response SLAs: set explicit timings for acknowledgement, initial triage, containment, stakeholder notification, and post-incident review.
  • Human override rules: state when outputs must be quarantined, hidden, or reviewed before reuse.
  • Evidence retention: agree which prompts or input context, outputs, model versions, downstream actions and review notes may be retained, with access restrictions and a retention schedule.
  • Closure standard: require root cause review, remediation, sign-off, and lessons learned updates.

Assess your AI risk and exception handling controls

Which governance controls should be public versus internal?

Ask clinical safety, legal and security owners which information belongs in an external summary and which belongs in internal runbooks. A summary might cover roles, exception categories, agreed response targets and review requirements. Keep sensitive on-call contact details, security escalation logic and system-specific workarounds restricted to the appropriate teams.

Check any proposed publication against applicable reporting duties, confidentiality requirements and the audience's information needs.

Recommended SLA structure for high-risk output exceptions

Have the clinical safety lead set response targets for the intended use, patient impact, care setting and available coverage. Use the following phases to organise that discussion:

  • Acknowledgement: specify the owner, contact route, target and arrangements outside covered hours.
  • Initial triage: agree a target for risk classification and the decision on pausing or restricting the workflow.
  • Clinical review: define how potential patient harm, unsafe guidance or protocol deviation reaches the responsible clinical reviewer, with an agreed target.
  • Containment action: assign authority and targets for model rollback, rule suppression, output quarantine or workflow disablement where appropriate.
  • Stakeholder update: identify the clinical, governance and operational recipients, update targets and applicable notification duties.
  • Root cause and remediation plan: agree investigation and remediation milestones, including any earlier actions needed for patient safety.

Document the targets agreed for the care setting, coverage model and system criticality. Have legal reviewers check reporting duties, and test whether the responsible teams can meet the plan.

What should happen the moment a high-risk exception is detected?

Follow the deployment's approved clinical incident process. Have the clinical safety lead define immediate care-protection actions, human review and restriction authority. Use the following record outline alongside that response; it is not a fixed sequence for patient care.

  1. Record the output, permitted input context, timestamp, system state and affected workflow using the approved evidence and access arrangements.
  2. Assign a severity level using a pre-agreed rubric.
  3. Route to the accountable clinical and technical owners.
  4. Decide whether the output, feature, or model path should be paused.
  5. Document whether any patient-facing or clinician-facing action occurred.
  6. Record all subsequent review, remediation, and sign-off steps.

Exercise the contact route and handoffs. Record gaps in reviewer availability or authority and resolve them before relying on the proposed process.

How audit trails support defensible exception handling

Link high-risk events to records of the system output, reviewer, controls triggered and final disposition. Use those records to compare actual response times with the agreed targets.

Agree the evidence needed for internal, supplier and governance reviews and post-incident learning. Consider model version, reviewer identity, timestamps, remediation notes and closure approval. Retain prompt/input context and output snapshots only within the agreed permissions, access controls and retention rules.

Design a governance operating model that stands up to review

Common mistakes in published clinical AI exception policies

Check whether wording such as "we review high-risk issues promptly" identifies an owner and an agreed target. Specify which exceptions require clinical governance input as well as technical incident handling.

Check the handoffs between product, data, compliance and clinical leadership. Identify who may suspend a workflow, who owns clinical sign-off and who carries agreed changes into the system.

The safest approach in practice

Agree a care-setting-specific framework with control categories, severity-based response targets, human review triggers and permitted audit evidence. Record the responsible roles and decide which parts each stakeholder needs to see.

Exercise the approved process and compare the response with its targets. Keep the resulting actions, review decisions and unresolved gaps with the deployment record.

Build clinical AI controls into delivery, not as an afterthought

Want to find the practical AI opportunity?

For an enquiry about a live clinical workflow, ask what the assessment would cover: potential time savings including review effort, risks, and the controls to validate before rollout.

Frequently asked questions

Should clinical AI teams publish exact on-call names and internal contacts?

No. They should publish the governance structure and accountable roles, while keeping sensitive contact detail in internal runbooks.

Do all high-risk exceptions need clinician review?

Have the clinical safety lead define which exceptions need clinician review, the applicable coverage hours and the response target for the care setting. Test the route and record gaps rather than assume a standard SaaS SLA covers patient-safety decisions.

How detailed should the published SLA be?

Define the acknowledgement, triage, containment, review and closure targets agreed for the deployment. Match the detail shared to the audience and keep operational contacts in the restricted runbook.

Can standard incident management policies cover this?

Have clinical safety and legal owners check whether the existing incident policy covers the intended use, human review, evidence and clinical accountability. Record any required additions.

What is the minimum viable governance publication?

Agree the audience before publication. A summary can cover exception categories, roles, agreed response targets, review triggers, evidence requirements and escalation principles, subject to clinical safety, legal and security review.

Discuss your next step

Talk through your situation with Rohit, or take the assessment if you need a first read.